• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Global Medical REIT Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    6/23/25 7:24:57 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate
    Get the next $GMRE alert in real time by email
    false 0001533615 0001533615 2025-06-20 2025-06-20 0001533615 us-gaap:CommonStockMember 2025-06-20 2025-06-20 0001533615 us-gaap:SeriesAPreferredStockMember 2025-06-20 2025-06-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(D) OF THE 

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): June 23, 2025 (June 20, 2025)

     

    Global Medical REIT Inc.

    (Exact name of registrant as specified in its charter)

     

    Maryland 001-37815 46-4757266

    (State or Other Jurisdiction

    of Incorporation)

    (Commission

    File Number)

    (I.R.S. Employer

    Identification No.)

     

    7373 Wisconsin Avenue, Suite 800

    Bethesda, MD

    20814

    (Address of Principal Executive Offices)

    (Zip Code)

     

    (202) 524-6851

    (Registrant’s Telephone Number, Including Area Code)

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class:   Trading Symbols:   Name of each exchange on which registered:
    Common Stock, par value $0.001 per share   GMRE   NYSE
    Series A Preferred Stock, par value $0.001 per share   GMRE PrA   NYSE

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    Transition of Jeffrey M. Busch

     

    As previously disclosed on January 8, 2025, Global Medical REIT Inc. (the “Company”), Jeffrey M. Busch and Inter-American Management LLC (“IAM”) entered into a Transition and Separation Agreement and General Release of Claims, pursuant to which the Company, IAM and Mr. Busch agreed that Mr. Busch’s employment, and service as Chief Executive Officer and President of the Company, would end no later than the first to occur of (i) the date that a successor to the position of Chief Executive Officer, who is appointed in accordance with the Board’s (as defined below) approved succession process, begins employment or (ii) June 30, 2025. In connection with the appointment of a successor to the position of Chief Executive Officer (as disclosed below), on June 20, 2025, Mr. Busch was removed from his position as Chief Executive Officer and President of the Company, effective June 23, 2025. Mr. Busch will continue to serve on the board of directors of the Company (the “Board”) as non-executive Chairman.

     

    Appointment of Mark O. Decker, Jr. as Chief Executive Officer and President

     

    On June 20, 2025, Mark O. Decker, Jr, age 49, was appointed Chief Executive Officer and President of the Company, effective as of June 23, 2025. Commencing upon the effectiveness of Mr. Decker’s appointment, Mr. Decker will act as the Company’s principal executive officer.  The Board also increased the size of the Board from seven directors to eight directors and appointed Mr. Decker as a director effective June 23, 2025, to hold office until the Company’s 2026 annual meeting of stockholders and until his successor is duly elected and qualified.

     

    Mr. Decker was most recently a Managing Partner at Proterra Value Investors, where he co-led the Net Lease strategy, from May 2023 to June 2025. From April 2017 to March 2023, Mr. Decker served as President, Chief Executive Officer and Chief Investment Officer and as a member of the board of trustees of Centerspace (NYSE: CSR), a NYSE-listed real estate investment trust, focused on the ownership, management, acquisition, development and redevelopment of apartment communities. From August 2016 to April 2017, Mr. Decker served as the President and Chief Investment Officer of Centerspace. From 2011 to 2016, he served as Managing Director and U.S. Group Head of Real Estate Investment and Corporate Banking at BMO Capital Markets, the North American-based investment banking subsidiary of the Canadian Bank of Montreal. In addition, Mr. Decker served as a director for Alpine Income Property Trust (NYSE: PINE) from November 2019 until October 2024. Mr. Decker earned a Bachelor of Arts in History from the College of William & Mary.

     

    There are no arrangements or understandings between Mr. Decker and any other persons pursuant to which he was appointed as Chief Executive Officer and President of the Company. Further, there are no arrangements or understandings between Mr. Decker and any other persons pursuant to which he was appointed to the Board. There are no family relationships between Mr. Decker and any of the Company’s directors or executive officers, and Mr. Decker is not a party to any transaction, or any proposed transaction, required to be disclosed pursuant to Item 404(a) of Regulation S-K.

     

    Employment Agreement with Mr. Decker

     

    In connection with his appointment as Chief Executive Officer and President of the Company, IAM and Mr. Decker entered into an Employment Agreement (the “Agreement”), effective as of June 23, 2025 (the “Effective Date”).

     

    Term

     

    The Agreement has an initial three-year term commencing on the Effective Date, with automatic renewals of additional successive one-year periods unless either party provides at least 90 days’ advance notice of non-renewal.

     

     

     

     

    Duties

     

    The Agreement requires that Mr. Decker devote all of his business time and attention to the performance of his duties to the Company, but it allows Mr. Decker to engage in certain other outside activities, so long as those duties and activities do not reasonably interfere with his performance of his duties to the Company.

     

    Compensation and Benefits

     

    The Agreement provides for certain compensation and benefits, including but not limited to:

     

    ·Base Salary: An annual base salary of $700,000 (the “Base Salary”).
    ·Annual Bonus: Beginning with calendar year 2026, a target annual cash bonus opportunity of at least 100% of Base Salary (the “Target Annual Bonus”), payable in a mix of cash and LTIP Units (as defined in the Global Medical REIT Inc. 2016 Equity Incentive Plan) and subject to achievement of performance criteria and targets established and administered by the Board (or a committee thereof). For the 2025 calendar year, Mr. Decker shall be eligible to receive a prorated Target Annual Bonus for the portion of the year that he is employed by the Company following the Effective Date, payable 60% in cash and 40% in LTIP Units.
    ·Initial LTIP Award: On the Effective Date, a one-time award of LTIP Units with a grant-date value equal to $1,000,000, which vests in full on the third anniversary of the Effective Date.
    ·2026 LTIP Award: For the 2026 calendar year, an LTIP Unit award with a target aggregate dollar value of $1,200,000, with terms and conditions (including the allocation between time-based and performance-based vesting) to be set by the Compensation Committee of the Board.
    ·Other Benefits: A cash payment of $75,000 to assist Mr. Decker with relocation to the Washington, D.C. area. Mr. Decker shall also be eligible to participate in all employee benefit programs made available to similarly situated Company employees.

     

    Severance Payments

     

    The Agreement provides that, if Mr. Decker’s employment is terminated due to expiration of the then-existing term, as a result of a non-renewal of the Agreement by the Company, by the Company without cause or by Mr. Decker for good reason (a “Qualifying Termination”), subject to Mr. Decker executing and not revoking a release of claims, Mr. Decker will receive the following severance entitlements: (1) two times the sum of: (a) his Base Salary and (b) the greater of (i) his Target Annual Bonus with respect to the year of termination or (ii) his actual bonus with respect to the year preceding the year of termination (the “Severance Payment”); (2) a prorated annual bonus for the year of termination (the “Termination Bonus Payment”); (3) all outstanding time-based equity-based awards vest (the “Accelerated Vesting”), and performance-based equity awards will vest if and to the extent the applicable performance-based vesting conditions are satisfied with any such amount pro-rated for the actual number of days in the applicable performance period preceding the effective date of termination (the “Ongoing Vesting”); and (4) continuation of subsidized health care coverage for up to 18 months or monthly payments equal to the Company cost of providing such coverage (the “COBRA Subsidy”).

     

    If the Qualifying Termination occurs within the six (6) month period prior to a change in control (as generally defined below), on the date of a change in control, or within the twelve (12) month period following a change in control, subject to Mr. Decker executing and not revoking a release of claims, Mr. Decker will receive the Severance Payment, the Termination Bonus Payment, the Accelerated Vesting, the Ongoing Vesting, and the COBRA Subsidy; provided, however, that (i) the Termination Bonus Payment shall be calculated based on actual achievement of the applicable performance goals through the date of the change in control, (ii) with respect to the Ongoing Vesting, any performance-based vesting awards shall vest based on actual performance measured through the date of the change in control, and (iii) with respect to the Severance Payment, such amount shall be equal to three (3) times (or, one (1) times in certain circumstances) the sum of (a) Mr. Decker’s Base Salary for the year in which such termination occurs and (b) his Target Annual Bonus for the year in which such termination occurs or the actual bonus paid to Mr. Decker with respect to the preceding year, whichever is greater.

     

    If Mr. Decker’s employment is terminated due to death or disability, he (or his estate, as applicable) shall be eligible to receive the Termination Bonus Payment, the Accelerated Vesting, the Ongoing Vesting, and the COBRA Subsidy, subject to his execution and non-revocation of a general release.

     

     

     

     

    For purposes of the Agreement, “good reason” generally means, (i) a material diminution in the Mr. Decker’s title, authority, duties, or responsibilities, (ii) a material breach by the Company of its obligations to Mr. Decker under the Agreement, (iii) a 50-mile relocation of Mr. Decker’s principal place of employment from the Company’s headquarters in Bethesda, Maryland or (iv) any requirement that Mr. Decker report to a corporate officer of the Company instead of reporting directly to the Board.

     

    For purposes of the Agreement, “Cause” generally means Mr. Decker’s (i) material breach of the Agreement or any other written agreement between the Company (or its subsidiaries) and Mr. Decker, (ii) material breach of any workplace law or the Company (or its subsidiaries) written policies and codes of conduct, (iii) commission of an act of fraud, theft, dishonesty, embezzlement or breach of fiduciary duty related to the Company (or its subsidiaries) or the performance of his duties under the Agreement, (iv) commission of an act of gross negligence or willful misconduct related to the Company (or its subsidiaries) or the performance of his duties under the Agreement, which results in material and demonstrable damage to the Company (or its subsidiaries), (v) conviction of, or plea of guilty or nolo contendere to, a felony (or state law equivalent) or any crime involving moral turpitude or the indictment of Mr. Decker of any felony (or state law equivalent) of any crime involving moral turpitude, which is not discharged or otherwise resolved within 18 months, (vi) willful failure or refusal, other than due to disability, to perform his obligations under the Agreement or to follow any lawful directive from the board of directors of the Company or (vii) violation of certain of the restrictive covenants contained in the Agreement.

     

    For purposes of the Agreement, “change in control” generally means the occurrence of (i) the sale, transfer, conveyance or other disposition, in one or a series of related transactions, of all or substantially all of the Company’s properties or assets, (ii) a change in the majority of the Board, (iii) acquisition of 50% of more of the voting power of the Company’s stock, or (iv) the consummation of a reorganization, merger, consolidation, statutory share exchange or similar transaction after which the Company’s shareholders do not own, directly or indirectly, more than 50% of the voting power of the surviving entity’s (or a parent entity’s) stock.

     

    Non-Solicitation, Non-Competition, Intellectual Property, Confidentiality, and Non-Disparagement

     

    The Agreement contains standard confidentiality, non-disparagement, and invention assignment covenants as well as non-competition and non-solicitation restrictive covenants applicable during employment and for eighteen (18) months following Mr. Decker’s termination of employment.

     

    The description of the Agreement contained herein does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

     

    Indemnification Agreement

     

    In connection with his appointment as Chief Executive Officer and President of the Company and to the Board, the Company entered into a standard indemnification agreement with Mr. Decker, a form of which was filed as Exhibit 10.16 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Securities and Exchange Commission on February 28, 2025.

     

    Item 7.01 Regulation FD Disclosure.

     

    On June 23, 2025, the Company issued a press release announcing Mr. Decker’s appointment. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference.

     

    The information included in Item 7.01 of this Current Report on Form 8-K and the exhibit related thereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

     

     

     

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit No.    Description
    10.1   Employment Agreement by and between Mark O. Decker, Jr. and Inter-American Management LLC, effective as of June 23, 2025.
    99.1   Press Release dated June 23, 2025.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Global Medical REIT Inc.
         
      By: /s/ Jamie A. Barber
        Jamie A. Barber
        Secretary and General Counsel

      

    Date: June 23, 2025

     

     

    Get the next $GMRE alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $GMRE

    DatePrice TargetRatingAnalyst
    4/3/2025$9.00Neutral
    B. Riley Securities
    10/18/2024$11.75Buy
    Berenberg
    9/19/2024$12.00Buy
    Alliance Global Partners
    10/10/2022$9.00Outperform → Neutral
    Robert W. Baird
    10/6/2022$13.00 → $9.00Outperform → Market Perform
    BMO Capital Markets
    7/7/2022Mkt Perform
    JMP Securities
    1/13/2022Overweight → Sector Weight
    Keybanc
    9/20/2021$17.00Overweight
    Keybanc
    More analyst ratings

    $GMRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ortelius Director Nominees Release Joint Letter to Brookdale Stockholders

      Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock

      7/3/25 8:00:00 AM ET
      $BKD
      $GMRE
      $NTST
      $OHI
      Hospital/Nursing Management
      Health Care
      Real Estate Investment Trusts
      Real Estate
    • Global Medical REIT Appoints Mark Decker, Jr. as CEO

      Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that Mark Decker, Jr. has been appointed as the Company's Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of Directors, succeeds Jeffrey Busch, who will continue to serve on the Board as non-executive Chairman. Lori Wittman, Lead Independent Director of the Company stated, "We are extremely pleased to announce Mark Decker, Jr. as our new Chief Executive Officer. As part of the Board's ongoing commitment and efforts to maximize shareholder value, we identified the need for a fresh, strategic perspective to guide our portfolio management and growth initiatives. M

      6/23/25 7:00:00 AM ET
      $CSR
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • Global Medical REIT Inc. Board Declares 2025 Second Quarter Common and Preferred Dividends

      Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that its Board of Directors ("Board") has declared the Company's 2025 second quarter common and preferred dividends. Common Dividend The Board has declared the Company's 2025 second quarter cash dividend of $0.15 per share of common stock and unit, which is payable on July 9, 2025 to common stockholders and unitholders of record as of June 20, 2025. The Company has prepared an updated investor presentation which contains ce

      5/28/25 4:07:00 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate

    $GMRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO and President Decker Mark Okey Jr bought $1,042,528 worth of shares (160,000 units at $6.52) (SEC Form 4)

      4 - Global Medical REIT Inc. (0001533615) (Issuer)

      6/25/25 8:24:22 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 3 filed by new insider Decker Mark Okey Jr

      3 - Global Medical REIT Inc. (0001533615) (Issuer)

      6/25/25 8:22:33 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 4 filed by Director Wittman Lori

      4 - Global Medical REIT Inc. (0001533615) (Issuer)

      5/15/25 8:18:42 AM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate

    $GMRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley Securities resumed coverage on Global Medical REIT with a new price target

      B. Riley Securities resumed coverage of Global Medical REIT with a rating of Neutral and set a new price target of $9.00

      4/3/25 8:18:01 AM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • Berenberg initiated coverage on Global Medical REIT with a new price target

      Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75

      10/18/24 7:31:30 AM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • Alliance Global Partners initiated coverage on Global Medical REIT with a new price target

      Alliance Global Partners initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $12.00

      9/19/24 7:43:23 AM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate

    $GMRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO and President Decker Mark Okey Jr bought $1,042,528 worth of shares (160,000 units at $6.52) (SEC Form 4)

      4 - Global Medical REIT Inc. (0001533615) (Issuer)

      6/25/25 8:24:22 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate

    $GMRE
    SEC Filings

    See more
    • Global Medical REIT Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Global Medical REIT Inc. (0001533615) (Filer)

      6/23/25 7:24:57 AM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • Global Medical REIT Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - Global Medical REIT Inc. (0001533615) (Filer)

      5/28/25 4:36:27 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SCHEDULE 13G filed by Global Medical REIT Inc.

      SCHEDULE 13G - Global Medical REIT Inc. (0001533615) (Subject)

      5/15/25 6:06:16 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate

    $GMRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Ortelius Director Nominees Release Joint Letter to Brookdale Stockholders

      Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock

      7/3/25 8:00:00 AM ET
      $BKD
      $GMRE
      $NTST
      $OHI
      Hospital/Nursing Management
      Health Care
      Real Estate Investment Trusts
      Real Estate
    • Global Medical REIT Appoints Mark Decker, Jr. as CEO

      Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that Mark Decker, Jr. has been appointed as the Company's Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of Directors, succeeds Jeffrey Busch, who will continue to serve on the Board as non-executive Chairman. Lori Wittman, Lead Independent Director of the Company stated, "We are extremely pleased to announce Mark Decker, Jr. as our new Chief Executive Officer. As part of the Board's ongoing commitment and efforts to maximize shareholder value, we identified the need for a fresh, strategic perspective to guide our portfolio management and growth initiatives. M

      6/23/25 7:00:00 AM ET
      $CSR
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • Global Medical REIT Announces Succession Plan

      Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025 Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company,

      1/8/25 4:15:00 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate

    $GMRE
    Financials

    Live finance-specific insights

    See more
    • Global Medical REIT Inc. Board Declares 2025 Second Quarter Common and Preferred Dividends

      Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that its Board of Directors ("Board") has declared the Company's 2025 second quarter common and preferred dividends. Common Dividend The Board has declared the Company's 2025 second quarter cash dividend of $0.15 per share of common stock and unit, which is payable on July 9, 2025 to common stockholders and unitholders of record as of June 20, 2025. The Company has prepared an updated investor presentation which contains ce

      5/28/25 4:07:00 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • Global Medical REIT Announces First Quarter 2025 Financial Results

      – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financial results for the three months ended March 31, 2025 and other data. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the first quarter, we continued to deliver steady results supported by the high quality of our portfolio and stability of our tenant

      5/7/25 4:13:00 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • Global Medical REIT Inc. Announces Dates for 2025 First Quarter Earnings Release and Webcast

      Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today that it intends to release its first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025. The Company intends to hold a conference call to discuss those results the following day, Thursday, May 8, 2025, at 9:00 a.m. Eastern Time. The conference call will be hosted by Chairman, President, and Chief Executive Officer Jeffrey Busch, Chief Financial Officer Robert Kiernan, and Chief Investment Officer Alf

      4/15/25 4:15:00 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate

    $GMRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Global Medical REIT Inc. (Amendment)

      SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)

      1/25/24 4:59:30 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Global Medical REIT Inc. (Amendment)

      SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)

      2/9/23 11:19:25 AM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Global Medical REIT Inc. (Amendment)

      SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)

      1/31/23 1:58:04 PM ET
      $GMRE
      Real Estate Investment Trusts
      Real Estate